Immunoconjugates comprising tyrosine kinase inhibitors
US5872223A · kind A · utility
19Cited by
1References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 22, 1996 |
| Grant date | Feb 16, 1999 |
| Priority date | — |
| Expiry date | Nov 22, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Immunoconjugates effective for treating cancers and autoimmune diseases in humans are provided which comprise a tyrosine kinase inhibitor linked to a ligand targeting a cell surface receptor which are specifically capable of inhibiting receptor associated tyrosine kinases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.